Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: Temporary benefit but not without risk

Transplantation

Volumn 83, Issue 8, 2007, Pages 1041-1047

  Cransberg, Karlien ^a   Cornelissen, Marlies ^b   Lilien, Marc ^c   Van Hoeck, Koen ^d   Davin, Jean Claude ^e   Nauta, Jeroen ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Child; Cyclosporine; Kidney transplantation; Mycophenolate mofetil

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; HEMOGLOBIN; MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TRIACYLGLYCEROL;

ACUTE GRAFT REJECTION; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; MALE; MULTICENTER STUDY; OPEN STUDY; PATIENT COMPLIANCE; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT FAILURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENAL CORTEX HORMONES; BLOOD PRESSURE; CHILD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 34247467395     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000260146.57898.9c     Document Type: Article

References (25)

1. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet 1995; 345: 1321.
2. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation 1996; 61: 1029.
3. Ettenger R, Cohen A, Nast C, Moulton L, Marik J, Gales B. Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation. Transplant Proc 1997; 29: 340.
4. Cransberg K, Marlies Cornelissen EA, Davin JC, Van Hoeck KJ, Lilien MR, Stijnen T, et al. Improved outcome of pediatric kidney transplantations in the Netherlands - effect of the introduction of mycophenolate mofetil? Pediatr Transplant 2005; 9: 104.
5. McNally PG, Feehally J. Pathophysiology of cyclosporin A nephrotoxicity: Experimental and clinical observations. Nephrol Dial Transplant 1992; 7: 791.
6. van Rossum LK, Cransberg K, de Rijke YB, Zietse R, Lindemans J, Vulto AG. Determination of inulin clearance by single injection or infusion in children. Pediatr Nephrol 2005; 20: 777.
7. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am 1987; 34: 571.
8. van Rossum LK, Mathot RAA, Cransberg K, Zietse R, Vulto AG. Estimation of the glomerular filtration rate in children: Which algorithm should be used? Pediatr Nephrol 2005; 20: 1769.
9. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: A working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics 1996; 98: 649.
10. Cransberg K, van Gool JD, Davin JC, de Jong MCJW, Darby M, Boendermaker ME, et al. Pediatric renal transplantation in the Netherlands. PediatrTransplant 2000; 4: 72.
11. Hazzan M, Labalette M, Copin MC, Glowacki F, Provot F, Pruv FR, et al. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: Results from a prospective, randomized trial. J Am Soc Nephrol 2005; 16: 2509.
12. Schrama YC, Joles JA, van Tol A, Boer P, Koomans HA, Hene RJ. Conversion to mycophenolate mofetil in conjunction with stepwise withdrawal of cyclosporine in stable renal transplant recipients. Transplantation 2000; 69: 376.
13. Schnuelle P, van der Heide JH, Tegzess A, et al. Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen. J Am Soc Nephrol 2002; 13: 536.
14. Hollander AA, van Saase JL, Kootte AM, et al. Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation. Lancet 1995; 345: 610.
15. Smak Gregoor PJ, de Sevaux RG, Ligtenberg G, et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicenter study. J Am Soc Nephrol 2002; 13: 1365.
16. Ducloux D, Motte G, Billerey C, et al. Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: A 2-year follow-up. Transpl Int 2002; 15: 387.
17. Pijnenburg MW, Cransberg K, Wolff E, Bouquet J, Merkus PJ. Bronchiectasis in children after renal or liver transplantation: a report of five cases. Pediatr Transplant 2004; 8: 71.
18. Rook M, Postma DS, van der Jagt EJ, et al. Mycophenolate mofetil and bronchiectasis in kidney transplant patients: A possible relationship. Transplantation 2006; 81: 287.
19. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 2002; 61: 621.
20. Singh A, Tejani C, Benfield M, Tejani A. Sequential analysis of the lipid profile of children post-renal transplantation. Pediatr Transplant 1998; 2: 216.
21. Groothoff JW, Lilien MR, van de Kar NC, Wolff ED, Davin JC. Cardiovascular disease as a late complication of end-stage renal disease in children. Pediatr Nephrol 2005; 20: 374.
22. Benfield MR, McDonald R, Sullivan EK, Stablein DM, Tejani A. The 1997 annual renal transplantation in children report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatric Transplantation 1999; 3: 152.
23. MacPhee IA, Bradley JA, Briggs JD, et al. Long-term outcome of a prospective randomized trial of conversion from cyclosporine to azathioprine treatment one year after renal transplantation. Transplantation 1998; 66: 1186.
24. Lilien M, Duran M, Van Hoeck K, Poll-The BT, Schroder C. Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 1999; 14: 366.
25. van den Dorpel MA, van den Meiracker AH, Lameris TW, et al. Cyclosporine A impairs the nocturnal blood pressure fall in renal transplant recipients. Hypertension 1996; 28: 304.